1.785

1.42% 0.025

Eledon Pharmaceuticals Inc (ELDN)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Eledon Pharmaceuticals Inc stock is traded at $1.785, with a volume of 2.60M. It is up +1.42% in the last 24 hours and down -34.13% over the past month. Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Previous Close:

$1.76

Open:

$1.68

24h Volume:

2.60M

Relative Volume:

1.45

Market Cap:

$107.19M

Revenue:

Net Income/Loss:

$-40.33M

P/E Ratio:

-0.9972

EPS:

-1.79

Net Cash Flow:

$-39.53M

1W Performance:

-13.35%

1M Performance:

-34.13%

6M Performance:

-36.93%

1Y Performance:

-56.78%

1-Day Range:

$1.67

$1.83

1-Week Range:

$1.60

$2.40

52-Week Range:

$1.43

$5.08

Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile

Name

Eledon Pharmaceuticals Inc

Sector

Healthcare (1129)

Industry

Biotechnology (618)

Phone

949-238-8090

Address

19800 MACARTHUR BLVD., IRVINE

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

ELDN's Discussions on Twitter

Compare ELDN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ELDN Eledon Pharmaceuticals Inc	1.79	105.39M	0	-40.33M	-39.53M	-1.79
VRTX Vertex Pharmaceuticals Inc	440.70	110.25B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	696.17	73.04B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	455.47	59.98B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	906.11	54.90B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	195.11	40.73B	447.02M	-1.18B	-906.14M	-6.1812

Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-18-25	Resumed	H.C. Wainwright	Buy
Jan-28-25	Initiated	Guggenheim	Buy
May-13-22	Resumed	Cantor Fitzgerald	Overweight
Mar-23-21	Initiated	Cantor Fitzgerald	Overweight

Eledon Pharmaceuticals Inc Stock (ELDN) Latest News

06:43 AM

Market reaction to Eledon Pharmaceuticals Inc.’s recent newsPortfolio Growth Summary & Community Shared Stock Ideas - newser.com

06:43 AM

05:38 AM

What dividend safety rating applies to Eledon Pharmaceuticals Inc. (2TK) stockPortfolio Profit Report & Daily Chart Pattern Signals - Fundação Cultural do Pará

05:38 AM

02:04 AM

Published on: 2025-11-14 01:04:41 - newser.com

02:04 AM

02:02 AM

Why Eledon Pharmaceuticals Inc. (2TK) stock could be top winnerCEO Change & Fast Momentum Stock Entry Tips - newser.com

02:02 AM

01:16 AM

How analysts revise price targets for Eledon Pharmaceuticals Inc. (2TK) stockWeekly Stock Report & Technical Analysis for Trade Confirmation - newser.com

01:16 AM

Nov 13, 2025

Why Eledon Pharmaceuticals Inc. (2TK) stock stays on buy listsGold Moves & Risk Controlled Stock Alerts - newser.com

Nov 13, 2025

How Eledon Pharmaceuticals Inc. (2TK) stock valuation compares with sectorLong Setup & Fast Exit/Entry Strategy Plans - newser.com

Nov 13, 2025

Eledon Pharmaceuticals Announces $46.5M Public Offering - MSN

Nov 13, 2025

Visual trend scoring systems applied to Eledon Pharmaceuticals Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - newser.com

Nov 13, 2025

[424B5] Eledon Pharmaceuticals, Inc. Prospectus Supplement (Debt Securities) - Stock Titan

Nov 13, 2025

[8-K] Eledon Pharmaceuticals, Inc. Reports Material Event | ELDN SEC FilingForm 8-K - Stock Titan

Nov 13, 2025

Eledon Pharmaceuticals drops 10% on stock offering - MSN

Nov 13, 2025

Eledon prices $50 million public offering of stock and warrants By Investing.com - Investing.com Canada

Nov 13, 2025

Nov 12, 2025

Eledon Pharmaceuticals at Guggenheim Conference: Strategic Insights on Tegoprubart By Investing.com - Investing.com Australia

Nov 12, 2025

Midday Stock Roundup: Eledon falls 14% - Orange County Business Journal

Nov 12, 2025

Eledon Pharmaceuticals Shares Sink After Announcing $50 Million Public Offering - MSN

Nov 12, 2025

Eledon Pharmaceuticals Stock Plunges Following $50 Million Public Offering - FinancialContent

Nov 12, 2025

Midday Stock Roundup: Viant Tech Jumps on Earnings - Orange County Business Journal

Nov 12, 2025

Eledon Pharmaceuticals stock drops after pricing $50M public offering By Investing.com - Investing.com South Africa

Nov 12, 2025

Eledon Pharmaceuticals stock drops after pricing $50M public offering - Investing.com

Nov 12, 2025

Eledon Pharmaceuticals Prices $50 Million Public Offering - MarketScreener

Nov 12, 2025

Eledon Pharmaceuticals (ELDN) Reveals Details of $50M Public Off - GuruFocus

Nov 12, 2025

Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Nov 12, 2025

Eledon Pharma (NASDAQ: ELDN) prices $50M offering; adds 30-day underwriter option - Stock Titan

Nov 12, 2025

Can Eledon Pharmaceuticals Inc. stock resist sector downturnsM&A Rumor & Safe Capital Growth Stock Tips - newser.com

Nov 12, 2025

Nov 11, 2025

Eledon Pharmaceuticals launches public offering of common stock By Investing.com - Investing.com Nigeria

Nov 11, 2025

Eledon Pharmaceuticals (ELDN) Launches Public Offering - GuruFocus

Nov 11, 2025

Eledon Pharmaceuticals launches public offering of common stock - Investing.com India

Nov 11, 2025

Eledon Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants - The Manila Times

Nov 11, 2025

Eledon Pharmaceuticals Initiates Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Nov 11, 2025

Eledon Pharmaceuticals Announces Proposed Underwritten - GlobeNewswire

Nov 11, 2025

Eledon (NASDAQ: ELDN) begins underwritten offering of stock & pre-funded warrants - Stock Titan

Nov 11, 2025

What MACD signals say about Eledon Pharmaceuticals Inc.Trade Volume Summary & Entry Point Strategy Guides - newser.com

Nov 11, 2025

Using AI based signals to follow Eledon Pharmaceuticals Inc.2025 Buyback Activity & Consistent Profit Alerts - newser.com

Nov 11, 2025

Real time scanner hits for Eledon Pharmaceuticals Inc. explainedJuly 2025 Trade Ideas & Smart Swing Trading Techniques - newser.com

Nov 11, 2025

Nov 10, 2025

Can Eledon Pharmaceuticals Inc. recover in the next quarter2025 Bull vs Bear & Free Long-Term Investment Growth Plans - newser.com

Nov 10, 2025

Will breakout in Eledon Pharmaceuticals Inc. lead to full recovery2025 Winners & Losers & Safe Entry Momentum Tips - newser.com

Nov 10, 2025